Showing results (61-70 of 252) with videos related to

Sort By:
Pageof 26
Genes, Chromosomes & Cancer|August 1, 2017
Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanismsJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 8, 2026
Evolving Paradigms in the Treatment of Philadelphia Chromosome-Positive ALLNicholas J Short, Josep-Maria Ribera, Iman Abou Dalle, et al.
Leukemia & Lymphoma|April 12, 2003
Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprineJosé-Tomás Navarro, Josep-Maria Ribera, José-Luis Mate, et al.
Experimental Hematology|September 2, 2009
Metabolic fingerprinting of fresh lymphoma samples used to discriminate between follicular and diffuse large B-cell lymphomasIgnasi Barba, Carolina Sanz, Angels Barbera, et al.
Expert Review of Hematology|January 8, 2025
Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature reviewDavid I Marks, Ryan D Cassaday, Josep-Maria Ribera, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 12, 2020
Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in SpainJosep Maria Ribera Santasusana, Alejandra de Andrés Saldaña, Nuria García-Muñoz, et al.
Bone Marrow Transplantation|June 1, 2022
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalanFrancesca Guijarro, Alex Bataller, Marina Diaz-Beyá, et al.
Leukemia & Lymphoma|October 9, 2010
Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infectionBlanca Xicoy, Josep-Maria Ribera, José-Luís Mate, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2019
Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?Susanna Gassiot, Yolanda González, Mireia Morgades, et al.
International Journal of Hematology|December 7, 2007
Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapyJosé-Tomás Navarro, Josep-Maria Ribera, Albert Oriol, et al.
Pageof 26